-
useful information beyond established clinical risk scores. Phase 2: Linking clinical status to atrial electrical remodelling (n ~100): In a clinical ablation cohort, we will relate standard procedural
-
to quantify energy and nutrient intake patterns in people with asthma and overweight/obesity. These data will be linked with serum micronutrient markers (vitamin D, iron indices, calcium, B vitamins and trace
-
mycoprotein ABUNDA. This placement will provide hands-on experience of large-scale mycoprotein production linking fundamental biological research with industrial innovation and pre-market food technology. Using
-
) AMR Profiling: Map the baseline carriage of resistance genes in healthy vs. diseased populations, using metagenome-assembled genomes to link AMR determinants to specific microbes. 3) Workflow
-
-I) remains a viable alternative but to date few studies have explored its use in pregnancy. There is no conclusive data available on long term efficacy, maternal and neonatal outcomes and whether its
-
sequencing (NGS) data analysis. Through this interdisciplinary approach, the successful candidate will develop a highly sought-after skill set spanning clinical trials, microbiome science, molecular biology
-
provide considerable training in chronobiology, signal transduction in plants, microbiology, and data analysis and interpretation. As part of the “MicroClock” programme funded through an ERC Synergy grant
-
) 2:1. English Language requirement (MED/SCI equivalent: IELTS 6.5 overall, 6 in each category). Mode of study Full-time Start date 1 October 2026 Additional Funding Information This project is awarded
-
The minimum entry requirement is 2:1 (any degree with a substantial biological sciences component). Mode of study Full-time Start date 1 October 2026 Additional Funding Information This project is fully funded
-
date 1 October 2026 Additional Funding Information This PhD project is funded for four years by Big C with a contribution of £50,000 supported by the John & Pamela Salter Charitable Trust. Funding